Intelligent Current Deferred Revenue from 2010 to 2024
| INBS Stock | USD 1.61 0.10 6.62% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 2.5 M | Current Value 2.7 M | Quarterly Volatility 245.1 K |
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 158.8 K or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 0.89, Dividend Yield of 0.0 or PTB Ratio of 0.37. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
Intelligent | Current Deferred Revenue |
Latest Intelligent Bio's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Intelligent Bio Solutions over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Intelligent Bio's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Intelligent Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 2,228,872 | |
| Geometric Mean | 2,217,492 | |
| Coefficient Of Variation | 10.99 | |
| Mean Deviation | 190,649 | |
| Median | 2,098,884 | |
| Standard Deviation | 245,058 | |
| Sample Variance | 60.1B | |
| Range | 737.7K | |
| R-Value | 0.69 | |
| Mean Square Error | 34B | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 37,748 | |
| Total Sum of Squares | 840.7B |
Intelligent Current Deferred Revenue History
About Intelligent Bio Financial Statements
Intelligent Bio shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 2.5 M | 2.7 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.